Genetic Engineering & Biotechnology news features Taconic Biosciences because of their knowledge of animal models in ADME-Tox applications:
"To Focus Your Resources and Develop the Next Winning Drug, Try More Rigorous Assays and Models.
It may sound harsh, but drug candidates that are bound to be poor performers should be identified sooner rather than later--and ruthlessly eliminated from development. Granted, early in development, drugs tend to wade into the shallow end of the pharmacokinetic pool, and it can be hard to tell which drugs will thrash[...]"
"To Focus Your Resources and Develop the Next Winning Drug, Try More Rigorous Assays and Models. It may sound harsh, but drug candidates that are bound to be poor performers should be identified sooner rather than later--and ruthlessly eliminated from development. Granted, early in development, drugs tend to wade into the shallow end of the pharmacokinetic pool, and it can be hard to tell which drugs will thrash[...]"
Read the complete article at: Genengnews.com